STINGRAY THERAPEUTICS INC

STINGRAY THERAPEUTICS INC is a biotech company in Houston, United States, founded in 2022. It has raised $5.5M across 4 rounds, most recently a $1.5M Grant in August 2025.

Stingray Therapeutics | Best-in-Class ENPP1 Inhibitor for Cancer Immunotherapy

Headquarters
Houston, Texas
Employees
1–10
Founded
2022
Total Funding
$5.5M
Last Round
$1.5M GrantAug 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 1 investor for this company. The full record is or through the API.

About

Stingray Therapeutics develops Vizenpistat, an innate immune checkpoint inhibitor undergoing clinical trials across multiple cancer indications. By blocking ENPP1, Vizenpistat reactivates the cGAS-STING pathway and enables the immune system to fight cancer. Its approach addresses tumors that suppress innate immunity, with potential applicability across a wide range of tumor types.

Summary

It lists 1–10 employees. It has raised $5.5M in total across 4 rounds, most recently a $1.5M Grant round in Aug 2025. Investors include National Cancer Institute.

Funding History

Data from Indexed.vcUpdated
GrantSBIR Phase II (NIH)Aug 2025
$1.5M

Sign up to see all 4 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

STINGRAY THERAPEUTICS INC on Indexed.vc
<a href="https://indexed.vc/companies/stingray-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/stingray-therapeutics-inc" alt="STINGRAY THERAPEUTICS INC on Indexed.vc" width="260" height="76" /></a>